Principal Financial Group’s Audentes Therapeutics, Inc BOLD Stock Holding History

Principal Financial Group’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12,473	Closed	-$746K	–	2288
2019 Q4	$746K	Buy	+12,473	New	+$468K	﹤0.01%	1875
2019 Q3	–	Sell	-12,045	Closed	-$456K	–	2276
2019 Q2	$456K	Buy	12,045 +6,174	+105%	+$237K	﹤0.01%	1980
2019 Q1	$229K	Buy	+5,871	New	+$168K	﹤0.01%	2097
2018 Q4	–	Sell	-11,499	Closed	-$456K	–	2359
2018 Q3	$456K	Buy	11,499 +6,269	+120%	+$234K	﹤0.01%	1980
2018 Q2	$200K	Buy	+5,230	New	+$194K	﹤0.01%	2172

Principal Financial Group's BOLD Position: Q1 2020 in Review

Principal Financial Group sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 12,473 shares — an estimated $746K sold.

Principal Financial Group first reported a position in BOLD in Q2 2018 and held it in 5 quarters. The position peaked at $746K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Principal Financial Group reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Principal Financial Group sold 12,473 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $746K.
Principal Financial Group first reported a position in Audentes Therapeutics, Inc in Q2 2018 and held it in 5 quarters.
Principal Financial Group's Audentes Therapeutics, Inc position peaked at $746K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Principal Financial Group's 13F filing for Q1 2020, filed 12 May 2020.